ALG5
Basic information
Region (hg38): 13:36949738-37000763
Links
Phenotypes
GenCC
Source:
- polycystic kidney disease 7 (Limited), mode of inheritance: AD
- polycystic kidney disease 7 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Polycystic kidney disease 7 | AD | Renal | Treatment for hypertension and end-stage renal disease is frequently required, and nephrotoxic agents should be avoided | Gastrointestinal; Renal | 35896117 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALG5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 14 | 18 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 2 | 15 | 5 | 8 |
Variants in ALG5
This is a list of pathogenic ClinVar variants found in the ALG5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-36949955-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
13-36949991-C-A | not specified | Uncertain significance (Oct 30, 2023) | ||
13-36949991-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
13-36950001-T-C | not specified | Uncertain significance (Jun 28, 2022) | ||
13-36950023-T-G | not specified | Uncertain significance (Dec 15, 2022) | ||
13-36952574-T-C | not specified | Uncertain significance (Jul 06, 2021) | ||
13-36952580-G-C | not specified | Uncertain significance (Jan 08, 2024) | ||
13-36965575-C-T | Polycystic kidney disease 7 | Pathogenic (Oct 04, 2022) | ||
13-36965578-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
13-36965593-G-C | not specified | Uncertain significance (Nov 14, 2023) | ||
13-36965601-C-T | ALG5-related disorder | Likely benign (Oct 04, 2023) | ||
13-36965602-G-A | Polycystic kidney disease 7 | Uncertain significance (Mar 25, 2024) | ||
13-36965625-AAAT-A | Polycystic kidney disease 7 | Uncertain significance (Nov 29, 2023) | ||
13-36965643-C-G | Polycystic kidney disease 7 | Uncertain significance (Apr 04, 2024) | ||
13-36965643-CTG-C | Polycystic kidney disease 7 | Pathogenic (Oct 04, 2022) | ||
13-36965654-T-C | not specified | Uncertain significance (Aug 14, 2023) | ||
13-36965676-C-T | Polycystic kidney disease 7 | Likely pathogenic (Dec 06, 2023) | ||
13-36965713-C-T | Polycystic kidney disease 7 | Pathogenic (Oct 04, 2022) | ||
13-36965714-G-A | ALG5-related disorder | Uncertain significance (May 09, 2023) | ||
13-36965725-C-T | Polycystic kidney disease 7 | Pathogenic (Oct 04, 2022) | ||
13-36971985-T-C | ALG5-related disorder | Uncertain significance (Dec 26, 2023) | ||
13-36985628-G-C | not specified | Uncertain significance (Dec 20, 2021) | ||
13-36985701-C-T | ALG5-related disorder | Uncertain significance (Mar 21, 2024) | ||
13-36993668-C-T | not specified | Likely benign (Dec 15, 2022) | ||
13-36995037-T-C | Polycystic kidney disease 7 | Likely pathogenic (May 02, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALG5 | protein_coding | protein_coding | ENST00000239891 | 10 | 50487 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.463 | 0.536 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.01 | 143 | 181 | 0.790 | 0.0000100 | 2087 |
Missense in Polyphen | 31 | 59.827 | 0.51816 | 634 | ||
Synonymous | -0.279 | 65 | 62.2 | 1.04 | 0.00000321 | 628 |
Loss of Function | 3.50 | 5 | 23.2 | 0.215 | 0.00000145 | 238 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000875 | 0.0000875 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000481 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000743 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- N-Glycan biosynthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;dolichyl-diphosphooligosaccharide biosynthesis;Synthesis of dolichyl-phosphate-glucose;Synthesis of substrates in N-glycan biosythesis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;N-Glycan biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.150
Intolerance Scores
- loftool
- 0.551
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 60.09
Haploinsufficiency Scores
- pHI
- 0.319
- hipred
- N
- hipred_score
- 0.488
- ghis
- 0.516
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.949
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Alg5
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- protein glycosylation;protein N-linked glycosylation;determination of left/right symmetry;protein N-linked glycosylation via asparagine
- Cellular component
- endoplasmic reticulum membrane;membrane;integral component of membrane
- Molecular function
- oligosaccharyl transferase activity;dolichyl-phosphate beta-glucosyltransferase activity